Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 19:46 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- SAR 18.63T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | SAR 18.8B | SAR 53.66 | 3.96% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | SAR 35B | SAR 368.35 | 3.21% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | SAR 25B | SAR 369.25 | 2.82% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | SAR 19.4B | SAR 460.00 | 1.78% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | SAR 15.1B | SAR 110.49 | 1.15% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | SAR 27.7B | SAR 352.33 | 1.18% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | SAR 37B | SAR 244.68 | 1.35% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | SAR 18.1B | SAR 320.75 | 1.82% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | SAR 85.8B | SAR 74.81 | 1.65% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | SAR 106.5B | SAR 147.02 | 1.20% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | SAR 27.8B | SAR 79.86 | 2.70% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | SAR 32.5B | SAR 1,163.80 | 1.66% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | SAR 17B | SAR 155.63 | 0.29% up | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | SAR 146.4B | SAR 254.66 | 1.14% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | SAR 170.6B | SAR 146.21 | 7.70% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | SAR 118.5B | SAR 192.16 | 0.51% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | SAR 29B | SAR 172.85 | 1.64% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | SAR 257B | SAR 80.44 | 0.82% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | SAR 30.8B | SAR 471.28 | 1.20% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | SAR 21.7B | SAR 1,084.53 | 3.21% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | SAR 1.22T | SAR 495.47 | 4.13% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | SAR 17.4B | SAR 181.75 | 3.55% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | SAR 23.3B | SAR 574.00 | 2.05% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | SAR 56.9B | SAR 886.10 | 4.66% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | SAR 2.4T | SAR 998.44 | 2.39% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | SAR 23.4B | SAR 358.95 | 3.47% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | SAR 4.53T | SAR 5,087.44 | 1.91% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | SAR 448.6B | SAR 219.47 | 1.76% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | SAR 63.2B | SAR 963.48 | 4.98% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | SAR 361.2B | SAR 3,491.97 | 1.54% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | SAR 495.4B | SAR 1,954.12 | 2.89% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | SAR 49.8B | SAR 99.65 | 0.51% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | SAR 1.07T | SAR 567.62 | 2.50% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | SAR 1.87T | SAR 1,060.75 | 1.13% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | SAR 89.8B | SAR 2,109.17 | 2.61% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | SAR 57.3B | SAR 294.36 | 0.60% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | SAR 30.4B | SAR 438.98 | 1.69% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | SAR 45.1B | SAR 232.60 | 0.94% up | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | SAR 172B | SAR 1,505.43 | 0.56% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | SAR 591.1B | SAR 103.70 | 1.48% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | SAR 23B | SAR 163.00 | 0.80% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | SAR 46.7B | SAR 55.99 | 0.36% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | SAR 360.1B | SAR 179.65 | 1.41% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | SAR 1.02T | SAR 656.29 | 2.12% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | SAR 21.1B | SAR 30.98 | 2.48% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | SAR 415.2B | SAR 172.92 | 2.16% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | SAR 26.7B | SAR 507.81 | 1.03% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | SAR 26.8B | SAR 245.20 | 3.57% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | SAR 674.9B | SAR 389.65 | 0.57% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | SAR 641.4B | SAR 145.52 | 1.61% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | SAR 26.9B | SAR 192.95 | 0.23% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | SAR 18.2B | SAR 104.67 | 0.34% up | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | SAR 18.6B | SAR 222.27 | 1.62% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | SAR 125.2B | SAR 308.26 | 3.96% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | SAR 34.6B | SAR 1,490.10 | 0.21% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | SAR 27.1B | SAR 309.89 | 1.45% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | SAR 32B | SAR 39.97 | 1.48% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | SAR 118.9B | SAR 541.98 | 20.61% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | SAR 11.7B | SAR 60.13 | 1.35% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | SAR 16.8B | SAR 100.92 | 1.77% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | SAR 75.2B | SAR 561.22 | 0.15% up | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 19:46 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of SAR 18.63T as of 19 Nov 2026, 19:46 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.